The incidence of elderly patients with rocuronium combined continuous infusion of dexmedetomidine pre injection of muscle relaxant effect and residual effect

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-CIC-16008519

Enrollment

Unknown

Registered

2016-05-23

Start date

2016-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle relaxant effect and residual effect

Interventions

none:none

Eligibility

Sex/Gender

All

Age

20 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective abdominal surgery, study group: 65-85 years old, the control group: 20-50 years old, volunteered to participate in this trial and signed informed consent.

Exclusion criteria

Exclusion criteria: Electrode gel allergy, neuromuscular junction disease, participating in other clinical research, posture and surgical interference TOF-Watch SX normal work and abnormal function of the liver and kidney, installed pacemaker, myopathy, around neuropathy, slow paralysis, taking drugs affecting neuromuscular transmission or the influence of rocuronium metabolism of drugs,BMI>=25 or <=18kg/m2, T<32 degree C.

Design outcomes

Primary

Measure	Time frame
Residual muscle relaxation;	—

Countries

China

Contacts

Public ContactZhen Zhouhe

Department of Anesthesiology, Renji South Hospital, School of Medicine, Shanghai Jiao Tong University

sandyhezz@126.com+86 13816533785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026